CorMedix SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 19, 2026, 8 a.m. ETView on SEC.gov
Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedCorMedix Announces FDA Acceptance with Priority Review of REZZAYO sNDA for Prophylaxis of Invasive Fungal Disease; PDUFA Date Set for Q1 2027
8-KAug. 13, 2026, 7:32 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
8-KAug. 7, 2026, 4:18 p.m. ETView on SEC.gov
Other events · Financial statements and exhibits